Contracts › 75N93022C00041
75N93022C00041: Advancing Vaccine Adjuvant Research for Tuberculosis
Awarded to University of Sydney by National Institutes of Health (NIH).
$14.1Mobligated
$14.1Mpotential value
29 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N93022C00041 |
|---|---|
| Awardee | University of Sydney |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Offers received | 5 |
| Period of performance | 30 September 2022 to 29 September 2027 |
| Potential end | 29 September 2027 |
| Estimated recompete solicitation | ~Q2 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record